Hanall Biopharma Completes Disposal of 66,004 Treasury Shares

Hanall Biopharma submitted a report on disposal of treasury shares on May 6, 2026, disposing of 66,004 registered common shares.
The disposal resulted from stock option exercises, with the disposal price per share being the weighted average of exercise prices per tranche.
Post-disposal treasury share holdings are not separately stated in the report.

ADVERTISEMENT (250px+)